Universe Pharmaceuticals Inc
4 hedge funds and large institutions have $181K invested in Universe Pharmaceuticals Inc in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
87% less capital invested
Capital invested by funds: $1.4M → $181K (-$1.22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$19.1K |
| 2 |
Renaissance Technologies
New York
|
+$7.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$891K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PVI
1
Pura Vida Investments
New York
| $150K | -$891K | -233 | -78% |
|
|
2
Renaissance Technologies
New York
| $13K | +$7.65K | +2 | +50% |
|
|
TSS
3
Two Sigma Securities
New York
| $10K | +$19.1K | +5 | New |
|
4
Acadian Asset Management
Boston,
Massachusetts
| $8K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$1K | – | – |
|
UPC Hedge Fund Activity: Q2 2022 in Review
4 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q2 2022, worth a combined $181K — down 87% from $1.4M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new UPC positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $19.1K. The largest seller was Pura Vida Investments, cutting an estimated $891K.
- 4 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q2 2022, up from 3 in Q1 2022.
- Funds reported $181K of Universe Pharmaceuticals Inc stock for Q2 2022, down 87% quarter-over-quarter.
- 1 fund opened new Universe Pharmaceuticals Inc positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Universe Pharmaceuticals Inc buyer in Q2 2022 was Two Sigma Securities, an estimated $19.1K added.
- The largest Universe Pharmaceuticals Inc seller in Q2 2022 was Pura Vida Investments, an estimated $891K sold.
Based on aggregated 13F filings for Q2 2022.